Search for: "Teva Pharmaceuticals"
Results 461 - 480
of 1,423
Sort by Relevance
|
Sort by Date
10 Feb 2017, 10:52 am
February 8, 2017), the Court granted defendant Teva Pharmaceuticals USA, Inc. [read post]
8 Feb 2017, 3:09 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
25 Jan 2017, 11:25 pm
However, claim 27 is to “a pharmaceutical composition comprising a compound according to any one of claims 1-25 together with a pharmaceutically acceptable carrier and optionally other therapeutic ingredients” (emphasis added). [read post]
19 Jan 2017, 2:42 pm
Teva, the international pharmaceutical company, was revealed to have paid bribes to Russian, Ukrainian and Mexican officials, and would have to pay nearly $500 million in penalties. [read post]
18 Jan 2017, 1:28 pm
Staying with patents, as IPKat member Neil Wilkof discusses on IP Finance the challenges faced by the world’s largest generic drug company, Teva Pharmaceutical Industries Ltd (based in Israel), but whose most successful product in recent years has been the proprietary drug COPAXONE. [read post]
16 Jan 2017, 5:44 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
12 Jan 2017, 12:42 pm
;Teva Pharmaceuticals USA, Inc.; and Barr Laboratories,Inc. [read post]
12 Jan 2017, 11:11 am
There is no pharmaceutical company that better reflects the challenges of trying to master both these product markets than the Israeli-based company, Teva Pharmaceutical Industries Ltd. [read post]
9 Jan 2017, 9:36 am
Teva Pharmaceutical was able to reformulate Copaxone into an extended-release medication that only needs to be taken three times a week. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
28 Dec 2016, 10:06 am
On December 22, 2016, Teva Pharmaceutical Industries Ltd. [read post]
27 Dec 2016, 2:50 pm
The world’s largest manufacturer of generic pharmaceuticals, Israeli-based Teva Pharmaceutical Industries Ltd. [read post]
22 Dec 2016, 7:49 am
The defendant drug makers include: Mylan, Teva Pharmaceuticals, Citron Pharma, Heritage Pharmaceuticals, Aurobindo Pharmaceuticals, and Mayne Pharmaceuticals. [read post]
15 Dec 2016, 11:44 am
(Paul Buckowski / Times Union) Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma, Mayne Pharma, Mylan Pharmaceuticals and Teva Pharmaceuticals USA are being targeted by the lawsuit. [read post]
19 Nov 2016, 4:48 am
Teva Pharmaceuticals USA, Inc., Civil Action No. 14-874-SLR (D.Del., November 16, 2016), the Court found the asserted claims of U.S. [read post]
15 Nov 2016, 7:18 am
The AP reports that Teva Pharmaceutical announced that it would cease sales of its migraine patch treatment Zecuity (sumatriptan iontophoretic transdermal system) due to reports from patients that it caused “burns and scars where it was applied. [read post]
14 Nov 2016, 9:16 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
8 Nov 2016, 11:53 pm
Among the generic drug companies experiencing this share price decline were Allergan, Teva Pharmaceuticals, and Endo Pharmaceuticals. [read post]
13 Oct 2016, 6:50 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
8 Oct 2016, 3:25 am
Plaintiffs, Endo Pharmaceuticals Inc. and Mallinckrodt LLC, filed these patent infringement actions against defendants Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York, LLC (collectively, “Amneal”), Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. [read post]
